Akili, the company behind video game-like prescription and over-the-counter digital therapeutics for individuals with ADHD, has signed a definitive merger agreement with mental health and fitness ...
After announcing it would start selling its assets earlier this year and lay off nearly half the company, the medical app developer Akili Interactive has found a willing buyer. Virtual Therapeutics, ...
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, today announced U.S. Food and Drug Administration (FDA) clearance of EndeavorOTC Ⓡ (AKL-T01) as an over-the ...
A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...
The Roblox vision for bringing people together through shared experiences, plus the Akili commitment to a new era of cognitive medicine, make the companies ideal partners to deliver a reimagined ...
Maker of the first-and-only FDA-cleared prescription video game treatment joins the ranks of Canva, Microsoft, SpaceX, and more BOSTON--(BUSINESS WIRE)-- Akili Interactive Labs, Inc. (“Akili”), a ...
Digital therapeutics company Akili said Tuesday it is reducing its workforce by 46% and exploring strategic alternatives. Akili, which has developed video game therapies for people with attention ...
Akili (NASDAQ:AKLI) stock rose ~38% on Wednesday after the company reported results from a trial of video game-based therapy EndeavorRx to treat adults with attention ...
Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will participate in the Cowen 43 rd Annual Health Care Conference in Boston next month. On March 8, Akili sessions are scheduled for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results